China Biomaterial Industry Market Foresight and Investment Strategy Report, 2013-2017

Currently, China biomaterial science and project has begun to enter the international advancing level while the biomaterial consumption ranks the third in the world. As China’s economy is continuously increasing, some international top research institutes and top 500 corporations pay more and more attention to China biomaterial market. The biomaterial research and industry development in Japan and South Korea, which are next to China, are showing a strong growth trend. It is predicted that Asia will be the major market for biomaterial in the following years.

Generally speaking, biomaterial refers to biomedical-oriented material and biomedical material. China is a country with over 1.3 billion populations and among which 60 million are the disabled. According to the report of Civil Affairs Department, number of the physically disabled is over 15 million, among which number of the amputee is about 8 million and the Kaschin-Beck's Disease which is caused by rheumatoid disease is millions; number of the CHD patient has exceeded 10 million; number of the cataract blind is about 5 million while that of the tooth defect and anodontia is as high as 300 million to 400 million which is 1/4 to 1/3 of the whole population of China. In spite of this, China is going to be an aging society that number of the elder who is over 60 years old in 2011 is 178 million, which is 13.26% of the whole population. The tissue and organ lesion which is caused by aging needs timely treatment and it requires a large number of high-quality biomedical materials and machinery.

Market space of biomedical materials in China is huge. Presently, localization rate of the domestic commonly used biomedical products, such as disposable products (for example, disposable syringes, infusion sets, blood collection and blood bags), dressing, medical seam (needle) and condom are 80%, 70%, 60% and 90%. Meanwhile, market demand of implanted biomedical products greatly increases. There are 180,000 sets of artificial joints for clinical use, 390,000 sets of spinal implanted device, 190,000 sets of implanted tooth as well as 430,000 sets of coronary stent in 2009. Moreover, potential annual demand of such surgical implanted products is 10 times more than that of the actual usage amount. It requires 50,000 sets of IOL annually according to the state “sight emersion plan”. Domestic annual demand of catheter which implant in the body is 100 million, while that of artificial cardiac valve is about 250,000, pacemaker is about 400,000, artificial joints and vascular stents both are about 500,000 sets. In the meantime, demand of bone substitute materials is increasing. Accordingly, market prospects of biomedical-oriented materials are booming.

As regular biomedical products with low technology content, people pay less attention to it. Still, the biomedical product market accounts 1/4 of the whole medical machinery market, and 1/2 of the whole biomedical material and artificial organ market.

The modern medicine is developing towards the directions like regeneration and reconstruction of damaged human tissues and organs; restore and enhance the physiological functions; personalized and minimally invasive treatment and so on. The traditional lifeless materials of medical metal, macromolecule and biological ceramics cannot meet the need of medical development. There are new opportunities and challenges for biomedical material science and project. It is predicted that in the near future, that the market share of biomedical material will be same as medicine. Therefore, the first imperative is to enhance the clinical applied research and application of biomedical materials, and focus on developing an integrated system which closely connects biomedical materials research, development, production and marketing together.

With decades of investment and supports from government, China biomedical material gets a significant progress in the field of scientific research, among which papers and patent applications that are published in 2009 rank top in the world. In the meantime, there are some industry giants of strength and prospects in China, such as Lepu Medical Technology (Beijing) Co., Ltd., MicroPort Medical (Shanghai) Co., Ltd., Grandhope Biotech Co., Ltd., Weigao Holding Company Limited. and Trauson Holdings Company Limited. Among which the Grandhope Biotech Co., Ltd. is listed on July, 2011. Its business transfers from OEM to Establishment of a wholly-owned manufacturing plant and new product R&D center for oversea corporations. We are confident that China biomedical material industry will be better and better and take an important position in the global market in the near future.

Currently, China biomaterial science and project has begun to enter the international advancing level while the biomaterial consumption ranks the third in the world. As China’s economy is continuously increasing, some international top research institutes and top 500 corporations pay more and more attention to China biomaterial market. The biomaterial research and industry development in Japan and South Korea, which are next to China, are showing a strong growth trend. It is predicted that Asia will be the major market for biomaterial in the following years.

Here, we’d like to express our sincere gratitude to National Statistics Bureau of China, International Information Institute, National Institute of the Ministry of Commerce, National Tsing Hua University Library, Institute of Market Economy of the State Council Development Research Center, and Beijing Qinghua Forward Market Research Center, etc. Thank you so much!

Notice: all the market data, especially the corporation list data in this report is only for business reference. Please don’t take the data for enterprise publicity. Thank you! Or Forward shall not take any responsibility for any consequences!

Qianzhan Business Information Co., Ltd. Industry Research College
Research Team of Biomaterial Industry